gg/igm double antibody is 15 minutes out of the accuracy of more than 90% or even up to 98%COVID 19 diagnostic kit is used for the qualitative detection of new coronavirus (2019-nCoV) antibodies in human whole blood, serum and plasma.
Coronavirus (CoV) belongs to the order Nestivirus, Coronaviridae, and divided into three genera: �±, �², and �³. The alpha and beta gene are only pathogenic to mammals. The gamma gene mainly causes bird infections. CoV is mainly transmitted through direct contact with secretions or through aerosols and droplets. There is also evidence that it can be transmitted through the fecal-oral route.
There have been seven types of human coronavirus (HCoCoV and 2019-nCoV), which are important pathogens of human respiratory tract infection.Among them, the new coronavirus (2019-nCoV) was found for 2019 cases of viral pneumonia in Wuhan. The clinical manifestations are systemic symptoms such as fever, fatigue, dry cough, dyspnea, which can quickly develop into severe pneumonia, respiratory failure, acute Respiratory distress syndrome, toxic shock, multiple organ failure, severe acid-base metabolism disorders and even life-threatening.
2019-nCoV Antibody Diagnostic Kit uses the principle of immunochromatographic method to qualitative detect the coronavirus (2019-nCoV) antibody in human whole blood, serum and plasma. It is used for clinical diagnosis of primary infection or secondary infection of new type of coronavirus infection pneumonia.
Contraindications, precautions, warnings, and instructions:
Found that the original packaging is damaged and prohibited to use.
Sterilized with ethylene oxide.
Contact Directly
This products is limited to one-time use and is it destroyed after use.
Prohibited to use after the expiration date.
1. Generic Name: Novel Coronavirus COVID-19 IgG Antigen Test Kit
2. Brand Name: NIL
3. Notified Category: Other than above substances intended for qualitative determination of COVID-19 infection
4. Class of Medical Device: Class D
5. Shelf life :15 months
6. Sterile/Non-Sterile: Non-Sterilized
7. Contains Drugs: No
8. Medical Device Grouping Category: IVD-Kit
9. Grouping Description: Intended for qualitative determination of COVID-19 infection
10. Intended Use: The Novel Coronavirus COVID-19 IgG Kit is intended for the qualitative detection of human anti-COVID- 19 IgG antibody in human serum/plasma. Any reactive specimen with the Novel Coronavirus COVID-19 IgG Kit must be confirmed with alternative testing method(s).
11. Product Description: Assay controls and 1:10 diluted human serum samples are added to the microtiter wells of a microplate that was coated with COVID-19 recombinant full length recombinant protein. After the first incubation period, the unbound protein matrix is removed with a subsequent washing step. A horseradish peroxidase (HRP) labeled polyclonal goat anti-human IgG tracer antibody is added to each well. After an incubation period, an immunocomplex of "COVID-19 recombinant antigen-human anti-COVID-19 IgG antibody - HRP labeled anti human IgG tracer antibody" is formed if there is specific Coronavirus IgG antibody present in the tested specimen. The unbound tracer antibody is removed by the subsequent washing step. HRP-Labeled tracer antibody bound to the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the tracer antibody bound to the anti-COVID-19 IgG on the wall of the microtiter well is proportional to the amount of the anti-COVID-19 IgG antibody level in the tested specimen.
SALIENT FEATURES:
â?¢ Recombinant COVID-19 Spike subunit Protein coated on Microwell Plate
â?¢ HRP Conjugated Polyvalent Anti-Human IgG
â?¢ Assay Time: 80 mins (30mins+30 Mins+20mins)
â?¢ Strip Format Microwell Plate
â?¢ Ready to use Substrate and Controls
â?¢ Only 20 pL of human serum is required for measurement in duplicate.
â?¢ Works on any open ELISA system
â?¢ Assay procedure is easy to automate
OUR TEST:
â?¢ Principle: Indirect ELISA
â?¢ The normal healthy patients with samples collected prior to the COVID-19 outbreak [December 3, 2019] (n = 150) and RT-PCR confirmed positive patients in after the second week of the onset of the disease (n = 32). The Positive sample evaluation was done at external Approved Lab. The results are as follows:
â?¢ Diagnostic sensitivity is 100% (>98%)
â?¢ Diagnostic specificity is 98.67% (>97%)
â?¢ PPV: 94.12�°/0
â?¢ NPV: 100%
Please contact us for more information and product details.
Dermaqual is a Reputed French Biomedical Laboratory since 2003. We produced the world-first Coronavirus (COVID-19) "Sanitized" Test Kit. Its CE & ISO Certified.
The test kit will take only 10-15 min. to show if you are infected. We are looking for Distributors in EMEA region.
One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG antibody (Colloidal Gold) is intended for the qualitative detection of 2019-Novel Coronavirus IgM and IgG antibody in serum, plasma or whole blood samples from patients suspected of COVID-19 infection by a healthcare provider.
A kit contains:
Package specifications: 25 tests/box
1) Getein Novel Coronavirus (2019-nCoV) IgM/IgG antibody test card in a sealed pouch with desiccant
2) Sample diluent: 2 bottles/box
3) User manual: 1 piece/box
Colloidal Gold igg igm Immunocartography Covid19 test kit
The sensitivity of IgM test is 88% and specificity is 94.7%
The sensitivity of IgG test is 84% and specificity is 97.4%
MOQ 50K units @3.6 US, 20/box
ISO13485 SGS/CE certified
Terms EXW/TT
